This index is particularly useful for healthcare professionals, researchers, and individuals seeking detailed information about specific branded pharmaceutical product.
Monographs serve as essential reference for clinical particulars such as drug composition and administration guidelines, indications, contraindications and adverse reactions.
| Document | Type | Information Source | |
|---|---|---|---|
| MYALEPTA Powder for solution for injection | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| MYAMBUTOL Film-coated tablet | MPI, US: SPL/Old | FDA, National Drug Code (US) | |
| MYBULEN Capsule | MPI, Generic | Health Products Regulatory Authority (ZA) | |
| MYCAMINE Powder for solution for infusion | MPI, EU: SmPC | European Medicines Agency (EU) | |
| MYCAPSSA Gastro-resistant hard capsule | MPI, EU: SmPC | European Medicines Agency (EU) | |
| MYCLAUSEN Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| MYCOBUTIN Capsules | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| MYCOKEM 500 Film-coated tablet | MPI, EU: SmPC | Pharmaceutical Benefits Scheme (AU) | |
| MYCORIL Vaginal tablet | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| MYCOSTATIN Oral suspension | MPI, EU: SmPC | Health Products Regulatory Authority (IE) | |
| MYDFRIN 2.5% w/v Ophthalmic solution | MPI, CA: SPM | Health Products and Food Branch (CA) | |
| MYDOFLEX Film-coated tablet | MPI, EU: SmPC | Υπουργείο Υγείας (CY) | |
| MYDRIACYL Eye drops, solution | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| MYDRILATE 1.0% Eye drops | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| MYFORTIC Gastro-resistant tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| MYKRONOR Solution for injection / infusion | MPI, EU: SmPC | Health Products Regulatory Authority (IE) | |
| MYLATAF Film-coated tablet | MPI, Generic | Health Products Regulatory Authority (ZA) | |
| MYLERAN Film-coated tablet | MPI, US: SPL/Old | FDA, National Drug Code (US) | |
| MYLOTARG Powder for concentrate for solution for infusion | MPI, EU: SmPC | European Medicines Agency (EU) | |
| MYONAL Tablets / Granules | MPI, US: SPL/PLR | ||
| MYOPRIDIN Tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| MYOVIEW Kit, Powder for solution for injection | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| Myozyme 50 mg, powder for concentrate for solution for infusion | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| MYOZYME Powder for concentrate solution | MPI, EU: SmPC | European Medicines Agency (EU) | |
| MYRELEZ Solution for injection | MPI, EU: SmPC | Health Products Regulatory Authority (IE) | |
| MYSILDECARD Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| MYSIMBA Prolonged-release tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| MYSODELLE Vaginal delivery system | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| MYSOLINE Tablet | MPI, US: SPL/Old | FDA, National Drug Code (US) | |
| MYTESI Delayed-release tablet | MPI, US: SPL/PLR | FDA, National Drug Code (US) |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.